SPOTLIGHT: Pfizer to turn Esperion back to Newton

Pfizer snapped up Esperion Therapeutics four years ago, hip to its cholesterol candidates, but shut it down last year. Now, Esperion will relaunch as a private company with its previous leader, Roger Newton, at the helm. Report